www.barrons.com
Open in
urlscan Pro
2600:9000:21f3:3600:14:c68f:c40:93a1
Public Scan
URL:
https://www.barrons.com/articles/this-biotech-company-sees-dna-testing-as-formula-for-growth-51651734020?mod=past_editions
Submission: On May 11 via api from CH — Scanned from DE
Submission: On May 11 via api from CH — Scanned from DE
Form analysis 1 forms found in the DOM
<form autocomplete="off">
<div id="scrim-from-wrap" class="input-wrap">
<label for="scrim-from">From</label>
<textarea id="scrim-from" readonly="readonly" disabled="disabled" type="text" autocomplete="off" autocorrect="off" autocapitalize="none"></textarea>
</div>
<div id="scrim-to-wrap" class="input-wrap">
<label for="scrim-to">To</label>
<input id="scrim-to" type="text" autocomplete="off" autocorrect="off" autocapitalize="none">
</div>
<div class="input-wrap">
<label for="scrim-message">Message</label>
<textarea id="scrim-message" class="msg" maxlength="500" type="text" autocomplete="off" autocorrect="off" autocapitalize="none"></textarea>
</div>
</form>Text Content
We've detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser. CHROME SAFARI FIREFOX We've detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser.GoogleFirefox Search News & Quotes Barron's TopicsStock PicksMagazineDataAdvisorPenta100 Years Subscribe Now |Sign In Barrons This Biotech Company Finds DNA Testing Is the Right Formula for Growth Next: Tech Is Getting Crushed. 2 Stocks to Buy Amid the Wreckage. * * * * Share This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com. https://www.barrons.com/articles/this-biotech-company-sees-dna-testing-as-formula-for-growth-51651734020 * Biotech and Pharma * European Trader THIS BIOTECH COMPANY FINDS DNA TESTING IS THE RIGHT FORMULA FOR GROWTH * * * * -------------------------------------------------------------------------------- By Rupert Steiner May 5, 2022 3:00 am ET * Order Reprints * Print Article OXFORD NANOPORE TECHNOLOGIES PRODUCES COVID-19 TECHNOLOGY TO IDENTIFY NEW VARIANTS, AND TESTS AND ANALYZES DNA. Courtesy Oxford Nanopore Technologies Biotech company Oxford Nanopore Technologies, which listed on the London market eight months ago, produces Covid-19 technology to identify new variants, but its expertise in testing DNA and analyzing data is where its growth lays. Its technology, with more than 2,000 patents, could disrupt the sequencing market, and is superior to rivals because of the combination of its portability, ability to process real-time data, and skill in reading ultralong DNA fragments. Potential applications stretch far beyond healthcare, and span... Subscribe or Sign In to continue reading -------------------------------------------------------------------------------- * Hedge Funds * Tech Trader TECH IS GETTING CRUSHED. 2 STOCKS TO BUY AMID THE WRECKAGE. * * * * -------------------------------------------------------------------------------- By Tae Kim Updated May 8, 2022 / Original May 6, 2022 * Order Reprints * Print Article Warren Buffett once said, “You don’t find out who’s been swimming naked until the tide goes out.” Well, the tide has gone out for technology-focused hedge funds. In the first four months of the year, tens of billions of investors’ capital has been vaporized in what could be the quickest collapse of dollar value in hedge fund history. Tiger... Subscribe or Sign In to continue reading -------------------------------------------------------------------------------- More from News Corp * Realtor.com Looking to buy your first home? You’ve come to the right place. * Mansion Global Bidding to Begin on the Most Expensive House for Sale in the U.S. * Realtor.com The Property Brothers (and Comic Ali Wong) Reveal the Very Best Outdoor Upgrades To Get This Summer * Financial News London Trading Places: JPMorgan poaches Aviva’s Singh, FCA hires ex-Goldman MD, BofA nabs Ansorg * Wall Street Journal Ron DeSantis Is Persona Non Grata at a Holocaust Memorial Close THIS BIOTECH COMPANY FINDS DNA TESTING IS THE RIGHT FORMULA FOR GROWTH Biotech company Oxford Nanopore Technologies, which listed on the London market eight months ago, produces Covid-19 technology to identify new variants, but its expertise in testing DNA and analyzing data is where its growth lays. From To Message SEND An error has occurred, please try again later. Thank you This article has been sent to Privacy Notice Cookie Notice Do Not Sell My Personal Information Copyright Policy Data Policy Accessibility Your Ad Choices Subscriber Agreement & Terms of Use Barron's Archive Corporate Subscriptions Manage Notifications Copyright ©2022 Dow Jones & Company, Inc. All Rights Reserved. Barron's Copyright ©2022 Dow Jones & Company, Inc. All Rights Reserved This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.